Stocks Result Analysis for Industry - Biotechnology for Q4 FY24-25 ending Mar 31, 2025
Analysis of which stocks have performed the best and worst in Industry - Biotechnology for Q4 FY24-25 on the basis of sales/revenues, profits and profit margins. Only companies which have declared results in the current quarter are considered.
Choose Stock universe, Portfolio or index
Note: Industry-level growth metrics have been calculated by totaling the numbers of all companies in that industry, to get an average.
1
POSITIVE PROFIT GROWTH
0
NEGATIVE PROFIT GROWTH
0
NEUTRAL PROFIT GROWTH
12.8
%
TOTAL REVENUE GROWTH
18.8
%
TOTAL EBIDT GROWTH
17.7
%
TOTAL OPER. PROFIT GROWTH
Positive
Negative
Pending
Revenue Growth
MAR-24
3917.1 Rs Cr
MAR-25
4417 Rs Cr
Highest Revenue Growth
Awaiting more industry results. Scroll down for table.
Profit Growth
MAR-24
135.5 Rs Cr
MAR-25
344.5 Rs Cr
Highest Profit Growth
Awaiting more industry results. Scroll down for table.
Operating Profit Growth
MAR-24
915.9 Rs Cr
MAR-25
1078.2 Rs Cr
Highest Operating Profit Growth
Awaiting more industry results. Scroll down for table.
| Stock | Market Capitalization | Operating Revenue Qtr | Revenue Growth Qtr YoY % | Revenue Surprise Qtr % | Net Profit Qtr | Net Profit Qtr Growth YoY % | Net Profit Surprise Qtr % | Operating Profit Qtr | Operating Profit Growth Qtr YoY % | EBITDA Qtr | EBITDA Qtr growth YoY % | Operating Profit Margin Qtr % | Operating Profit Qtr Margin% YoY Change | Last Result Updated |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Biocon |
39607.79
|
4417.00
|
12.76
|
0.00
|
344.50
|
154.24
|
-
|
1078.20
|
17.72
|
1135.50
|
18.81
|
24.41
|
1.03
|
08-May-2025 |
Powered by
